Section Arrow
Quote
ENLV.NASDAQ
- Enlivex Therapeutics Ltd
Quotes are at least 15-min delayed:2025/06/02 14:11 EDT
Last
 0.9679
+0.0319 (+3.41%)
Day High 
0.970248 
Prev. Close
0.936 
1-M High
1.15 
Volume 
14.53K 
Bid
0.9314
Ask
0.96
Day Low
0.9314 
Open
0.97 
1-M Low
0.92 
Market Cap 
22.32M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 0.97 
20-SMA 1 
50-SMA 0.98 
52-W High 1.76 
52-W Low 0.8101 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.73/-0.59
Enterprise Value
22.62M
Balance Sheet
Book Value Per Share
0.86
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
OGENOragenics0.172051+0.052051+43.38%-- 
PSTVPlus Therapeutics0.3801+0.0932+32.49%-- 
PCSAProcessa Pharmaceuticals0.2959+0.0034+1.16%-- 
BPMCBlueprint Medicines Corp127.57+26.22+25.87%-- 
IRDOpus Genetics Inc1.1308+0.1363+13.71%-- 
Quotes are at least 15-min delayed：2025/06/02 14:11 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.